Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
ClouDr GroupFRA:H3L 48 Days Inventory is 107.31 as of Dec. 2025, which is 210% above its 10-year median of 34.63. GuruFocus rates FRA:H3L with a GF Score™ of 48/100 and a GF Value™ of €0.08. The stock has 9 warning signs investors should review. Among 117 Medical Distribution companies, ClouDr Group ranks worse than 67.52% on this metric.
Days Inventory is also known as Days Sales of Inventory (DSI). ClouDr Group's Average Total Inventories for the
six
months ended in Dec. 2025 was €20.4 Mil. ClouDr Group's Cost of Goods Sold for the
six
months ended in Dec. 2025 was €34.7 Mil.
Hence, ClouDr Group's Days Inventory for the
six
months ended in Dec. 2025 was 107.31.
The historical rank and industry rank for ClouDr Group's Days Inventory or its related term are showing as below:
FRA:H3L'
s Days Inventory Range Over the Past 10 Years
Min: 25.9 Med: 34.63 Max: 111.95
Current: 72.17
During the past 7 years, ClouDr Group's highest Days Inventory was 111.95. The lowest was 25.90. And the median was 34.63.
FRA:H3L's Days Inventory is ranked worse than 67.52% of 117
companies
in the Medical Distribution industry
Industry Median: 54.88
vs FRA:H3L: 72.17
ClouDr Group's Days Inventory
increased
from Dec. 2024 (44.81) to Dec. 2025 (107.31).
It might indicate that ClouDr Group's sales slowed down.
Warning Sign:
If a company builds up inventory, it may mean it is having difficulties selling its goods.
Inventory Turnover measures how fast the company turns over its inventory within a year.
ClouDr Group's Inventory Turnover for the
six
months ended in Dec. 2025 was 1.70.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
ClouDr Group's Inventory-to-Revenue for the
six
months ended in Dec. 2025 was 0.23.
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
ClouDr Group's Inventory Turnover for the
six
months ended in Dec. 2025 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
ClouDr Group's Inventory to Revenue for the
six
months ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
ClouDr Group Days Inventory Related Terms
ClouDr Group Days Inventory Historical Data
* Premium members only.
The historical data trend for ClouDr Group's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:H3L vs MCK, COR, CAH: Days Inventory Comparison
For the Medical Distribution subindustry, ClouDr Group's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
ClouDr Group Days Inventory vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, ClouDr Group's Days Inventory distribution charts can be found below:
* The bar in red indicates where ClouDr Group's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ClouDr Group (FRA:H3L) has a Days Inventory of 107.31 as of Dec. 2025. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on ClouDr Group and its competitors. This is 210% above median its historical median of 34.63. Over the past decade, ClouDr Group's Days Inventory has ranged from 25.90 to 111.95. According to the industry distribution chart, ClouDr Group ranks #79 out of 117 companies in the Medical Distribution industry, placing it in the top 67.5%.
Is ClouDr Group's Days Inventory too high?
ClouDr Group's current Days Inventory of 107.31 is 210% above median its 10-year median of 34.63. Over the past 10 years, this metric has ranged from a low of 25.90 to a high of 111.95. The Medical Distribution industry median Days Inventory is 54.88. ClouDr Group's value of 107.31 is 95.5% above this industry median. Based on the distribution chart, ClouDr Group ranks #79 out of 117 companies in the Medical Distribution industry, which is below the industry midpoint. Overall, ClouDr Group has a GF Score™ of 48/100, reflecting its overall financial health beyond just this single metric.
How does ClouDr Group's Days Inventory compare to MCK and COR?
According to the Medical Distribution industry distribution chart, ClouDr Group ranks #79 out of 117 companies for Days Inventory. This places ClouDr Group in the lower half of its industry. The industry median Days Inventory is 54.88. ClouDr Group's value of 107.31 is 95.5% above this benchmark. Historically, ClouDr Group's own Days Inventory has ranged from 25.90 to 111.95 over the past decade. While the company's 10-year median is 34.63 vs. the industry median of 54.88, ClouDr Group has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Medical Distribution company?
The median Days Inventory among Medical Distribution companies is 54.88, based on 117 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. ClouDr Group's current Days Inventory of 107.31 is 95.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on ClouDr Group and its competitors. For the Medical Distribution industry, the median Days Inventory is 54.88 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. ClouDr Group's current Days Inventory is 107.31, which is 210% above median its own 10-year median of 34.63. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ClouDr Group stock overvalued right now?
ClouDr Group (FRA:H3L) has a current Days Inventory of 107.31. The stock's GF Value™ is €0.08, compared to a current price of €0.05 — trading 36.9% below its estimated fair value. The current Days Inventory is 107.31, which is 210% above median its 10-year median of 34.63 and 95.5% above the Medical Distribution industry median of 54.88. ClouDr Group's overall GF Score™ is 48/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For ClouDr Group (FRA:H3L), the current Days Inventory is 107.31 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is ClouDr Group (FRA:H3L) Overvalued in 2026?
Based on GuruFocus' analysis, ClouDr Group stock appears to be undervalued.
The current stock price of €0.05 is trading 36.9% below its estimated GF Value™ of €0.08.
Key valuation signals for FRA:H3L:
Days Inventory: 107.31 (210% above median its 10-year median of 34.63)
GF Value™: €0.08 vs. price of €0.05 (36.9% below fair value)
Industry Position: 95.5% above the Medical Distribution median (#79 of 117)
No single metric tells the full story. See the FRA:H3L stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
ClouDr Group Ltd provides supplies and SaaS to hospitals and pharmacies, digital marketing services to pharmaceutical companies, and online consultation and prescriptions to patients, all centered around chronic condition management. The company's in-hospital solution consists of sales of medical devices, consumables, and pharmaceuticals, hospital SaaS, and digital marketing services to pharmaceutical companies, and the out-of-hospital solution connects doctors and patients, and provides high-quality and trustworthy medical services through the AI vertical model ClouD GPT. The company generates revenues from sales of hospital and pharmacy supplies and individual chronic condition management products.
48GF Score
Get the complete analysis for FRA:H3L
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:H3L has been successfully added to your 
